RK STRATEGIES, INC.

RK STRATEGIES, INC. filed a registration for NEUROTHERA LABS, INC. on October 2, 2026.

Lobbying for NEUROTHERA LABS, INC. · Pharmaceutical company

Filing · LD-1 registration Registration

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 2, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Ontario

Lobbying activity 1

FDA issues pertaining to Orphan Drug Designation

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

SCISPARC LTD.

Israel · Tel Aviv · owns 100% of the client · contributed $10,000

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.